Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury
Haixia Li(Hubei University of Medicine), Hengwen Chen(Guang’anmen Hospital), Weilu Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Tan(Tsinghua–Berkeley Shenzhen Institute), Dong Chen(Quzhou City People's Hospital), Shanshan Li(First Affiliated Hospital of Zhengzhou University), Hao Zhou(Shanghai University), Xiaoqin Zhang(Beijing University of Chinese Medicine), Fan Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yinghao Zhi(Wenzhou Medical University), Xing Chang(Chinese Academy of Medical Sciences & Peking Union Medical College), Mingxian Chen(Central South University)
Cited by 20
Related Papers
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
|Nucleic Acids Research|2019|830
Anion insertion enhanced electrodeposition of robust metal hydroxide/oxide electrodes for oxygen evolution
|Nature Communications|2018|560
NPASS: natural product activity and species source database for natural product research, discovery and tool development
|Nucleic Acids Research|2017|266
Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting
|Proceedings of the National Academy of Sciences|2011|255